| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 16.15B | 16.75B | 15.71B | 11.81B | 12.92B | 9.64B |
| Gross Profit | 8.48B | 9.27B | 8.08B | 3.41B | 5.89B | 3.38B |
| EBITDA | 3.12B | 4.18B | 3.16B | 353.94M | 3.65B | 1.49B |
| Net Income | 2.08B | 2.75B | 2.00B | -216.28M | 2.42B | 816.03M |
Balance Sheet | ||||||
| Total Assets | 67.39B | 61.90B | 55.05B | 49.79B | 48.48B | 41.71B |
| Cash, Cash Equivalents and Short-Term Investments | 10.85B | 10.56B | 20.69B | 18.66B | 18.37B | 17.06B |
| Total Debt | 4.28B | 4.33B | 3.78B | 4.10B | 4.36B | 3.48B |
| Total Liabilities | 48.80B | 44.43B | 39.52B | 36.05B | 33.28B | 28.65B |
| Stockholders Equity | 18.04B | 16.92B | 14.98B | 13.15B | 14.72B | 12.80B |
Cash Flow | ||||||
| Free Cash Flow | 2.38B | 2.34B | 2.53B | 2.45B | 2.13B | 1.64B |
| Operating Cash Flow | 2.59B | 2.59B | 2.79B | 2.71B | 2.27B | 1.74B |
| Investing Cash Flow | -1.15B | -2.40B | -2.70B | -1.67B | -2.94B | -511.75M |
| Financing Cash Flow | -1.46B | -297.88M | -999.72M | -595.31M | 369.77M | 434.56M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | $27.08B | 13.44 | 11.86% | ― | -6.96% | -26.28% | |
79 Outperform | $12.72B | 12.66 | 9.03% | 8.03% | 5.41% | -23.52% | |
76 Outperform | $25.77B | 12.13 | 14.53% | 2.10% | -0.63% | -30.68% | |
76 Outperform | $21.80B | 15.17 | 8.15% | 0.23% | 6.06% | -8.53% | |
73 Outperform | $26.69B | 14.38 | 20.92% | 1.88% | 11.08% | 22.01% | |
68 Neutral | $18.00B | 11.42 | 9.92% | 3.81% | 9.73% | 1.22% | |
67 Neutral | $11.26B | 13.88 | 16.91% | 6.71% | ― | -10.75% |
In the third quarter of 2025, Markel Group Inc. reported a 7% increase in operating revenues and a 26% decrease in operating income, impacted by market movements in its equity portfolio. Adjusted operating income rose by 24%, highlighting improvements in underwriting profitability and net investment income. The company’s insurance segment saw an 11% increase in underwriting gross premium volume, and the combined ratio improved to 93%. The company also made significant changes to its financial reporting, including re-segmentation of businesses and expanded financial metrics, reflecting a strategic focus on transparency and operational efficiency.
The most recent analyst rating on (MKL) stock is a Buy with a $2108.00 price target. To see the full list of analyst forecasts on Markel stock, see the MKL Stock Forecast page.